Biolight Life Sciences Ltd
TASE:BOLT
Biolight Life Sciences Ltd
Income from Continuing Operations
Biolight Life Sciences Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Income from Continuing Operations
-₪27.5m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
Compugen Ltd
NASDAQ:CGEN
|
Income from Continuing Operations
-$16.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-3%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Income from Continuing Operations
-$8.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
See Also
What is Biolight Life Sciences Ltd's Income from Continuing Operations?
Income from Continuing Operations
-27.5m
ILS
Based on the financial report for Dec 31, 2023, Biolight Life Sciences Ltd's Income from Continuing Operations amounts to -27.5m ILS.
What is Biolight Life Sciences Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
1%
Over the last year, the Income from Continuing Operations growth was -216%. The average annual Income from Continuing Operations growth rates for Biolight Life Sciences Ltd have been -25% over the past three years , and 1% over the past ten years .